Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virus-specific lymphocytes for cytomegalovirus infection after allogeneic bone marrow transplantation
RBR-8zzwfnPhase 2Not yet recruiting
- Sponsor
- Hospital Israelita Albert Einstein
- Start
- Mar 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in cytomegalovirus disease (CMV), sponsored by Hospital Israelita Albert Einstein. Planned start Mar 2020; status: not yet recruiting.
02
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on RBR-8zzwfn.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8zzwfn.